RXRα provokes tumor suppression through p53/p21/p16 and PI3K-AKT signaling pathways during stem cell differentiation and in cancer cells
Open Access
- 10 May 2018
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (5) , 1-13
Abstract
: The retinoid X receptor alpha (RXRα) is an important therapeutic target impacting diverse biological processes. Activation of RXRα is known to suppress cancer cell growth. However, the cellular mechanism has been elusive. In the present study, we addressed its role during stem cell differentiation and the underlying connections with carcinogenesis. RXRα was significantly upregulated following the differentiation of human mesenchymal stem cell (hMSC) toward the formation of endothelial cell (EC). However, overexpression of RXRα in hMSC provoked a senescence-like phenotype accompanied by the elevation of tumor suppressor p53, p21, and p16. Consistently, RXRα level was suppressed in cancer cells (~five times lower compared to differentiated hMSC), and its elevation could inhibit the proliferation, migration, and angiogenesis of cancer cells. We further demonstrated that these inhibitory effects were related to RXRα’s interaction with estrogen receptor α (ERα) as well as EGF and ANGPTL3 through modulating PI3K/AKT signaling pathway by AKT and FAK phosphorylation. Moreover, RXRα inhibited glycolytic metabolism in cancer cells, which might be underlying its inhibition of differentiation and carcinogenic features. These data suggest that RXRα acts as a suppressor rather than a driving force during stem cell differentiation, and unbalanced RXRα can trigger multiple yet connected signaling pathways in preventing carcinogenesis.Keywords
This publication has 42 references indexed in Scilit:
- Variation in cancer risk among tissues can be explained by the number of stem cell divisionsScience, 2015
- Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1Proceedings of the National Academy of Sciences, 2011
- FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusionMolecular Biology of the Cell, 2011
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularizationExpert Opinion on Biological Therapy, 2009
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?Cell Cycle, 2009
- Tumor suppressors and cell metabolism: a recipe for cancer growthGenes & Development, 2009
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- A biomarker that identifies senescent human cells in culture and in aging skin in vivo.Proceedings of the National Academy of Sciences, 1995